Giant study found untrustworthy trials pollute gold-standard medical reviews
On Dec. 18, 2024, A huge collaboration has confirmed growing concerns that fake or flawed research is polluting…
On Dec. 18, 2024, A huge collaboration has confirmed growing concerns that fake or flawed research is polluting…
On Dec. 5, 2025, researchers Dr Sonia Shah and Dr Clara Jiang from the University of Queensland’s Institute…
On Nov. 28, 2024, scientists from King’s College London reported that an injection given during some asthma and…
On Nov. 21, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding $29.7 million to…
On Nov. 11, 2024, findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to…
On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
On Oct. 16, 2024, a National Institutes of Health (NIH)-funded clinical trial of an mpox vaccine in adolescents…
On Oct. 14, 2024, RedHill Biopharma announced that the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA)…
On Oct. 9, 2024, Novavax announced that the European Commission granted Marketing Authorization for Novavax’s updated 2024-2025 Nuvaxovid™…
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
On Oct. 2, 2024, results from a French clinical trial have identified what experts say should now be…
On Oct. 2, 2024, Eli Lilly and Company announced a $4.5 billion investment to create the Lilly Medicine…
On Sept. 20, 2024, study results released by Oregon Health & Science University (OHSU) researchers suggested placing defibrillation…
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
On Jul. 31, 2024, researchers at Washington State University (WSU) announced that the cannabigerol (CBG) effectively reduced anxiety…
On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345),…
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
On May 1, 2024, researchers at the National Institutes of Health (NIH) announced a review in JAMA that…
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
On Mar. 29, 2024, the California Institute for Regenerative Medicine (CIRM) announced awards that support 11 projects in…
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
On Dec. 5, 2023, Novartis announced that the U.S. Food and Drug Administration (FDA) had approved Fabhaltaᆴ (iptacopan)…
On Nov. 27, 2023, the CDCメs Tuberculosis Trials Consortium (TBTC) announced that it had launched an international clinical…
On Oct. 13, 2023, the National Institute of health (NIH) announced that an investigational drug, encaleret, restored calcium…